Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Cohen

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
Expert Review of Clinical Pharmacology|January 6, 2012
Dearth of clinically useful diagnostics limits growth of personalized medicineJoshua Cohen
International Journal of Health Services : Planning, Administration, Evaluation|June 13, 2003
State-based versus federal-based approaches to reducing the Medicare pharmaceutical coverage gapJoshua Cohen
Lancet (London, England)|August 8, 2006
WHO: strengthening the road to renewalJoshua Cohen
International Journal of Technology Assessment in Health Care|December 22, 2004
Are clinical practice guidelines impartial?Joshua Cohen
American Journal of Therapeutics|September 17, 2003
Switching omeprazole in Sweden and the United StatesJoshua Cohen
Lancet (London, England)|January 25, 2005
UNICEF: suggestions for changeJoshua Cohen
Health Affairs (Project Hope)|September 13, 2007
CEA is not a price controlJoshua Cohen
Pharmacoeconomics|February 8, 2013
Transatlantic convergence with respect to the fourth hurdle?Joshua Cohen
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 21, 2007
Comment on: Should we really worry about "launch delays" of new drugs in OECD countries? by L. Garatinni and S. GhislandiJoshua Cohen
Newsweek|September 17, 2008
The politics of preventionPeter Neumann, Joshua Cohen
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
Expert Review of Clinical Pharmacology|January 6, 2012
Dearth of clinically useful diagnostics limits growth of personalized medicineJoshua Cohen
International Journal of Health Services : Planning, Administration, Evaluation|June 13, 2003
State-based versus federal-based approaches to reducing the Medicare pharmaceutical coverage gapJoshua Cohen
Lancet (London, England)|August 8, 2006
WHO: strengthening the road to renewalJoshua Cohen
International Journal of Technology Assessment in Health Care|December 22, 2004
Are clinical practice guidelines impartial?Joshua Cohen
American Journal of Therapeutics|September 17, 2003
Switching omeprazole in Sweden and the United StatesJoshua Cohen
Lancet (London, England)|January 25, 2005
UNICEF: suggestions for changeJoshua Cohen
Health Affairs (Project Hope)|September 13, 2007
CEA is not a price controlJoshua Cohen
Pharmacoeconomics|February 8, 2013
Transatlantic convergence with respect to the fourth hurdle?Joshua Cohen
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 21, 2007
Comment on: Should we really worry about "launch delays" of new drugs in OECD countries? by L. Garatinni and S. GhislandiJoshua Cohen
Newsweek|September 17, 2008
The politics of preventionPeter Neumann, Joshua Cohen
Pageof 17